[144] WESTPORT FUEL SYSTEMS INC. SEC Filing
Westport Fuel Systems (WPRT) Form 144 notifies proposed sales of common shares on NASDAQ by an insider or affiliate. Two broker entries are listed: Morgan Stanley for 11,530 shares (aggregate market value $27,326.10) and Merrill EDGE for 23,640 shares (aggregate market value $56,026.80), with both sales dated 09/16/2025. Total outstanding shares reported in each line show 17,351,005. The filing also details the acquisition history for shares being sold: a mix of open-market purchases and multiple vesting events of restricted stock units between 03/27/2023 and 09/15/2025, with specific lot sizes listed. No sales in the past three months are reported. The filer affirms no undisclosed material adverse information.
- Detailed acquisition history is provided, showing dates and nature of each lot (RSU vesting and open-market purchase)
- Broker and sale date information are specified for the proposed transactions, aiding transparency
- Filer attestation that no undisclosed material adverse information is known
- None.
Insights
TL;DR: Insider proposes to sell 34,?170 common shares via two brokers on 09/16/2025, mostly from RSU vestings and some open-market purchases.
The Form 144 lists proposed dispositions of 11,530 shares through Morgan Stanley and 23,640 shares through Merrill EDGE, both on NASDAQ, with aggregate market values supplied per broker line. Acquisition records show most shares originate from multiple RSU vesting events (2024–2025) and an open-market purchase in March 2023. No prior sales in the past three months are reported, and the filer attests there is no nonpublic material adverse information. For investors, this is a routine report of an insider selling vested shares rather than a corporate disclosure of operational or financial change.
TL;DR: Filing documents routine insider disposition of vested shares with required attestation; no red flags in disclosures provided.
The notice includes required compliance language and lists the nature of acquisitions (RSU vestings and an open-market purchase). The schedule indicates proper aggregation of shares and identifies brokers and sale dates. Absence of reported sales in the prior three months simplifies assessment of recent insider trading activity. The representation regarding material adverse information is present, as required. The document appears procedural and compliant based on the information shown.